TTY Biopharm Co Ltd (4105) — Free Cash Flow Generation Index
TTY Biopharm Co Ltd (4105) has a Free Cash Flow Generation Index of 0.80x as of March 2026. Free cash flow of NT$525.88 Million represents 1% of operating cash flow (NT$654.16 Million). Explore how much does TTY Biopharm Co Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
TTY Biopharm Co Ltd Free Cash Flow Generation Index (2017–2025)
Historical FCF Generation Index trend for TTY Biopharm Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see TTY Biopharm Co Ltd operating cash flow efficiency.
Annual Free Cash Flow Generation for TTY Biopharm Co Ltd (2017–2025)
Year-by-year Free Cash Flow Generation Index for TTY Biopharm Co Ltd. Check 4105 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.91x | NT$1.61 Billion | NT$1.76 Billion | NT$150.83 Million | ▲ +1.5% |
| 2024 | 0.90x | NT$1.22 Billion | NT$1.35 Billion | NT$134.29 Million | ▼ -0.9% |
| 2023 | 0.91x | NT$985.73 Million | NT$1.09 Billion | NT$99.58 Million | ▲ +2.0% |
| 2022 | 0.89x | NT$1.10 Billion | NT$1.24 Billion | NT$135.50 Million | ▼ -5.4% |
| 2021 | 0.94x | NT$1.18 Billion | NT$1.26 Billion | NT$74.15 Million | ▲ +43.8% |
| 2020 | 0.65x | NT$344.49 Million | NT$526.35 Million | NT$181.86 Million | ▼ -30.5% |
| 2019 | 0.94x | NT$1.14 Billion | NT$1.21 Billion | NT$69.86 Million | ▲ +2.4% |
| 2018 | 0.92x | NT$987.49 Million | NT$1.07 Billion | NT$74.09 Million | ▲ +1.9% |
| 2017 | 0.90x | NT$899.03 Million | NT$996.52 Million | NT$96.79 Million | — |